PMID: J Res Pharm Pract. 2019 Jul-Sep;8(3):123-128. Epub 2019 Oct 16. PMID: 31728342 Abstract Title: The Association between Proton Pump Inhibitors and Myocardial Infarction: What Do Food and Drug Administration Data Tell Us? Abstract: Objective: There is limited and conflicting evidence on the association between proton pump inhibitors (PPIs) and myocardial infarction (MI). This study …
Continue reading “The association between proton pump inhibitors and myocardial infarction.”
PMID: Eur J Intern Med. 2019 Nov 14. Epub 2019 Nov 14. PMID: 31735546 Abstract Title: Use of proton pump inhibitors is associated with an increase in adverse cardiovascular events in patients with hemodialysis: Insight from the kids registry. Abstract: BACKGROUND: Proton pump inhibitors (PPIs) are known to increase the risk of mortality and cardiovascular …
PMID: Eur J Clin Pharmacol. 2019 Nov 21. Epub 2019 Nov 21. PMID: 31748819 Abstract Title: Proton pump inhibitors use and dementia risk: a meta-analysis of cohort studies. Abstract: PURPOSE: The aim of this study was to explore the relationship between proton pump inhibitors use and the risk of dementia.METHODS: A comprehensive literature search was …
PMID: Sci Rep. 2019 Nov 21 ;9(1):17280. Epub 2019 Nov 21. PMID: 31754136 Abstract Title: Proton-pump inhibitor use is associated with a broad spectrum of neurological adverse events including impaired hearing, vision, and memory. Abstract: Proton-pump inhibitors, PPIs, are considered effective therapy for stomach acid suppression due to their irreversible inhibition of the hydrogen/potassium pump …
PMID: Atherosclerosis. 2019 Nov 16 ;292:84-89. Epub 2019 Nov 16. PMID: 31785493 Abstract Title: Proton pump inhibitors and risk for recurrent ischemic events or death in outpatients with symptomatic artery disease. Abstract: BAGKGROUND AND AIMS: The influence of proton pump inhibitors (PPIs) on outcome in patients with symptomatic artery disease remains controversial.METHODS: FRENA is a …
PMID: Int J Mol Sci. 2019 Nov 25 ;20(23). Epub 2019 Nov 25. PMID: 31775230 Abstract Title: Cannabidiol-from Plant to Human Body: A Promising Bioactive Molecule with Multi-Target Effects in Cancer. Abstract: L. is a plant long used for its textile fibers, seed oil, and oleoresin with medicinal and psychoactive properties. It is the main …
Continue reading “The latest clinical evidence of the anticancer effects of CBD is also outlined.”
PMID: Int J Environ Res Public Health. 2019 Nov 12 ;16(22). Epub 2019 Nov 12. PMID: 31718076 Abstract Title: Cannabidiol Protects Dopaminergic Neuronal Cells from Cadmium. Abstract: The protective effect of cannabidiol (CBD), the non-psychoactive component of, against neuronal toxicity induced by cadmium chloride (CdCl10μM) was investigated in a retinoic acid (RA)-differentiated SH-SY5Y neuroblastoma cell …
PMID: Ther Adv Psychopharmacol. 2019 ;9:2045125319881916. Epub 2019 Nov 8. PMID: 31741731 Abstract Title: Cannabidiol as a potential treatment for psychosis. Abstract: Psychotic disorders such as schizophrenia are heterogeneous and often debilitating conditions that contribute substantially to the global burden of disease. The introduction of dopamine D2 receptor antagonists in the 1950s revolutionised the treatment …
Continue reading “Cannabidiol as a potential treatment for psychosis.”
PMID: Food Chem Toxicol. 2019 Nov 21:110992. Epub 2019 Nov 21. PMID: 31760075 Abstract Title: Concentrations of nine bisphenol analogues in food purchased from Catalonia (Spain): Comparison of canned and non-canned foodstuffs. Abstract: The present study was aimed at assessing the exposure of an adult population to nine BPs analogues (BPA, BPS, BPF, BPB, BPAF, …
n/a PMID: Environ Int. 2019 Nov 25 ;134:105328. Epub 2019 Nov 25. PMID: 31778932 Abstract Title: Peroxisome proliferator-activated receptor gamma (PPARγ) activation and metabolism disturbance induced by bisphenol A and its replacement analog bisphenol S using in vitro macrophages and in vivo mouse models. Abstract: Bisphenol A (BPA) and its replacement analog, bisphenol S (BPS), …
Health Time